Wessam Sonbol, CSM, CSPO, ICP-ACC
CEO
Delve Health

Wessam Sonbol is the Founder and CEO of Delve Health. He brings deep expertise in managing
complex Phase I–IV, IDE, and 510(k) clinical studies—working with elite partners like Medtronic,
Abbott Vascular, and Johnson & Johnson. Wessam champions decentralized trial models using
wearables, eConsent, TeleVisits, and real-time data analytics—driven by a belief that “patients
shouldn’t adapt to research, research should adapt to patients.” Wessam has dedicated his
career to simplifying and humanizing research journeys for patients and study teams. Delve
Health is actively redefining clinical trial infrastructure and engagement models to build what
patients and sponsors demand.